Chargement en cours...

Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy

Background: Although catalytic properties of different genetic polymorphisms of VKORC1 and CYP2C9 products have been identified, there is limited study available regarding warfarin dose requirement in Iranian patient population. This study investigates the impact of these polymorphisms on 115 patien...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Hematol Oncol Stem Cell Res
Auteurs principaux: Poopak, Behzad, Rabieipoor, Saghar, Safari, Nazila, Naraghi, Emadedin, Sheikhsofla, Fatemeh, Khosravipoor, Gelareh
Format: Artigo
Langue:Inglês
Publié: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748690/
https://ncbi.nlm.nih.gov/pubmed/26865929
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!